THA

5

Review clinical trials related to THA. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Binaural Beats for Postoperative Pain and Anxiety Reduction

To deliver a 30-minute binaural beats audio intervention in PACU and collect pain and anxiety outcomes immediately following surgery, and 4 hours following surgery completion in adults undergoing ambulatory total knee arthroplasty and total hip arthroplasty (TKA and THA).

Participants needed: 50
Trial details
Age: 18-99Biological sex: AllType: InterventionalSponsor: University of MiamiUpdated: Apr 30, 2026Locations: 1
Eligibility criteria

American Society of Anesthesiologists Physical Status Classification System (ASA... [+3]

Moderate-severe hearing impairment or use of hearing aids [+3]

Status: Recruiting

Bikini vs Longitudinal Incision in Direct Anterior Approach (DAA) Total Hip Arthroplasty (THA)

The study team is conducting this study to see if there is a difference between the wound healing and participant satisfaction rates between two incision types used during a THA done via the DAA technique.

Participants needed: 110
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University of MiamiUpdated: Mar 18, 2026Locations: 1
Eligibility criteria

Patients with body mass index greater than or equal to 30 [+2]

Patients with body mass index less than 30 [+4]

Status: Recruiting

Duloxetine for Perioperative Pain in Hip Arthroplasty: A RCT

The primary objective of this study is to compare total narcotic intake standardized via milligram morphine equivalents between duloxetine and placebo cohorts after a total hip arthroplasty.

Participants needed: 64
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: University of MiamiUpdated: Mar 18, 2026Locations: 1
Eligibility criteria

Patients > 18 years of age [+4]

Previous hemiarthroplasty or THA on ipsilateral hip [+13]

Status: Not yet recruiting

A Prospective Multicenter Clinical Study on the Efficacy and Safety of the Zirconia Ceramic Hip Joint Prosthesis System After Its Market Launch

This study adopted a prospective, multi-center, single-group target value trial design to evaluate the safety and efficacy of the hip joint prosthesis system produced by Beijing Anshou Technology Co., Ltd. in total hip arthroplasty. This clinical study selected seven clinical centers and recruited 290 subjects. Each center competed for enrollment, with the requirement that each center should undertake no less than 8 cases and no more than half of the total cases. The enrollment stopped when the total number of cases met the design requirements. After the patients signed the informed consent form, they entered the screening process. After the screening was successful, the hip joint prosthesis system produced by Beijing Anshou Technology Co., Ltd. was implanted, and follow-up was conducted for the patients at "before surgery, on the day of surgery, immediately after surgery until discharge, 2 weeks after surgery, 6 weeks after surgery, 3 months after surgery, 6 months after surgery, and 12 months after surgery." The demographic information and various evaluation indicators of the subjects were collected.

Participants needed: 290
Trial details
Age: 18-80Biological sex: AllType: ObservationalSponsor: Peking University Third HospitalUpdated: Feb 2, 2026Locations: 1Duration: 12 Months
Eligibility criteria

The patient's age ranges from 18 to 80 years old (inclusive), with no gender res... [+4]

There are contraindications for hip replacement surgery [+5]

Status: Not yet recruiting

The Q-REDUCE Study

The purpose of this study is to design a fast-track pathway for patients referred to the University Hospital of Southern Denmark, Esbjerg, with high probability of having a dislocated hip prosthesis with the primary aim to reduce the time from arrival to reduction and the total hospitalization time. Secondary aims are to * investigate whether quicker prosthesis reduction influences on hip function and quality of life afterwards * reduce the pain experience immediately and in the long term * increase patient satisfaction without changing the overall complication rate and readmission/mortality

Participants needed: 120
Trial details
Age: 18-99Biological sex: AllType: InterventionalSponsor: University of Southern DenmarkUpdated: Oct 15, 2024
Eligibility criteria

a history of either a THA or a HA in combination with at least one of the follow... [+2]

recurrent dislocations during the same hospital admission (already "in the house... [+6]